drugset / Trial / NCT00881413

Esomeprazole Versus Pantoprazole to Prevent Peptic Ulcer Rebleeding

NCT00881413 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this study is to compare the clinical effectiveness of intravenous esomeprazole and pantoprazole in preventing recurrent bleeding in the patients with high-risk bleeding peptic ulcers after successful standard endoscopic hemostasis.

Timeline

Start
—
Primary completion
—
Completion
—

Outcome

Outcome not reported

Stopped (Business): “problems in funding”

Drugs

EvaluationDrugModalityDoseRoute
Subject Esomeprazole Small molecule 8 mg Intravenous
Subject Esomeprazole Small molecule 40 mg Intravenous
Comparator Pantoprazole Other / unclassified 8 mg Intravenous
Comparator Pantoprazole Other / unclassified 40 mg Intravenous

Indications